Millipore Sigma Vibrant Logo

OP46 Anti-MDM2 (Ab-1) Mouse mAb (IF2)

This Anti-MDM2 (Ab-1) Mouse mAb (IF2) is validated for use in Frozen Sections Immunoblotting Immunofluorescence Immunoprecipitation Paraffin Sections for the detection of MDM2 (Ab-1).

Anti-MDM2 (Ab-1) Mouse mAb (IF2) : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Anti-Ubiquitin Protein Ligase, Anti-p53 Binding Protein, Anti-Murine Double Minute Chromosome-2

View Products on Sigmaaldrich.com
OP46
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

Species ReactivityHostAntibody Type
HMMonoclonal Antibody

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
OP46-100UG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 100 μg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewRecognizes the ~90 kDa (apparent MW) MDM2 protein. Also recognizes isoforms of ~57 kDa and ~74/76 kDa by immunoblotting.
      Catalogue NumberOP46
      Brand Family Calbiochem®
      SynonymsAnti-Ubiquitin Protein Ligase, Anti-p53 Binding Protein, Anti-Murine Double Minute Chromosome-2
      References
      ReferencesGorgoulis, V.G., et al. 1996. J. Pathol. 180, 129.
      Marchetti, A., et al. 1995. J. Pathol. 175, 31.
      Barak, Y., et al. 1993. EMBO J. 12, 461.
      Ladanyi, M., et al. 1993. Cancer Res. 53, 16.
      Leach, F.S., et al. 1993. Cancer Res. 53, 2231.
      Oliner, J.D., et al. 1993. Nature 362, 857.
      Momand, J., et al. 1992. Cell 69, 1237.
      Oliner, J.D., et al. 1992. Nature 358, 80.
      Fakharzadeh, S.S., et al. 1991. EMBO J. 10, 1565.
      Product Information
      FormLiquid
      FormulationIn 50 mM sodium phosphate buffer, 0.2% gelatin.
      Positive controlOSA-CL cells
      Preservative≤0.1% sodium azide (100 μg only)
      Quality LevelMQ100
      Applications
      Application ReferencesOriginal Clone, Frozen Sections Leach, F. S., et al. 1993. Cancer Res. 53, 2231. Paraffin Sections Marchetti, A., et al. 1995. J. Pathol. 175, 31.
      Key Applications Frozen Sections
      Immunoblotting (Western Blotting)
      Immunofluorescence
      Immunoprecipitation
      Paraffin Sections
      Application NotesFrozen Sections (1-5 µg/ml, see application references)
      Immunoblotting (0.5-2 µg/ml, chemiluminescence)
      Immunofluorescence (1-5 µg/ml)
      Immunoprecipitation (1 µg/sample)
      Paraffin Sections (1-5 µg/ml, heat pre-treatment required, see application references)
      Application CommentsAlthough the amino acid sequence of MDM2 predicts a protein with a molecular mass of approximately 54 kDa, MDM2 protein migrates on SDS/PAGE with an apparent mobility of 90 kDa.

      Immunoblotting Protocol
      MDM2 (Ab-1) can be used to detect MDM2 by Western blot of proteins previously separated by SDS/PAGE and electrophoretically transferred onto nitrocellulose membranes. The proteins are reacted with the monoclonal antibody and visualized using an HRP conjugated goat anti-mouse antibody with chemiluminescent detection.

      Materials
      Equipment:
      • Electrophoresis apparatus
      • Electroblotting apparatus
      • Rocker platform

      Solutions and Reagents
      • Anti-MDM2 (Ab-1) Mouse mAb (IF2) Cat. No. OP46 or OP46T
      • HRP conjugated goat anti-mouse IgG heavy and light chains (e.g. Cat. No. 401215)
      • Chemiluminescence detection system
      • ELB Buffer (include a cocktail of proetease inhibitors, such as 0.5 µg/ml leupeptin, 1 µg/ml pepstatin, 1 mM EDTA and 0.2 mM PMSF): 50 mM Hepes pH 7.0, 250 mM NaCl, 0.5 mM EDTA, 0.1% Nonidet P-40 Alternative
      • SDS-PAGE (7% acrylamide)
      • Phosphate buffered saline (PBS) pH 7.4; 1 Liter: 0.2 g KCl, 0.2 g KH2PO4, 8 g NaCl, 1.15 g Na2HPO4
      • PBS/0.1% Tween®-20 detergent (PBST)
      • 3% Non-fat Dry Milk in PBST

      Procedure
      1. Lyse cells in ELB Buffer. (Alternatively, cells can be lysed in RIPA Buffer or directly into 1x Laemmli Sample Buffer).
      2. Electrophorese 50-100 µg lysate using a 7% acrylamide gel.
      3. Transfer the protein samples from the polyacrylamide gel onto a nitrocellulose membrane using an electroblotting apparatus.
      4. Block the membrane for 1 h in PBST containing 3% non-fat dry milk at room temperature with rocking. Use about 1 ml per cm2 of membrane.
      5. Incubate the membrane with 1 µg/ml Anti-MDM2 (Ab-1) Mouse mAb (IF2) in 3% non-fat dry milk/ PBST for 1 h at room temperature with rocking.
      6. Wash the membrane 3 times, 15 min each, in PBST at room temperature with rocking.
      7. Incubate the membrane with HRP conjugated goat anti-mouse IgG heavy and light chain antibody, diluted according to the supplier’s instructions, in 3% non-fat dry milk/ PBST at room temperature for 1 h.
      8. Wash the membrane 4 times, 15 min each, in PBST at room temperature with rocking.
      9. Develop the membrane using chemiluminescent detection reagents according to manufacturer instructions.
      10. Expose the membrane to film for ten minutes. Adjust subsequent exposure times as needed.
      Biological Information
      Immunogenhuman MDM2
      ImmunogenHuman
      Epitopewithin amino acids 26-169 of human MDM2
      CloneIF2
      HostMouse
      IsotypeIgG2b
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Yes
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      OP46-100UG 04055977227215

      Documentation

      Anti-MDM2 (Ab-1) Mouse mAb (IF2) Certificats d'analyse

      TitreNuméro de lot
      OP46

      Références bibliographiques

      Aperçu de la référence bibliographique
      Gorgoulis, V.G., et al. 1996. J. Pathol. 180, 129.
      Marchetti, A., et al. 1995. J. Pathol. 175, 31.
      Barak, Y., et al. 1993. EMBO J. 12, 461.
      Ladanyi, M., et al. 1993. Cancer Res. 53, 16.
      Leach, F.S., et al. 1993. Cancer Res. 53, 2231.
      Oliner, J.D., et al. 1993. Nature 362, 857.
      Momand, J., et al. 1992. Cell 69, 1237.
      Oliner, J.D., et al. 1992. Nature 358, 80.
      Fakharzadeh, S.S., et al. 1991. EMBO J. 10, 1565.

      Brochure

      Titre
      Caspases and other Apoptosis Related Tools Brochure

      Citations

      Titre
    • Hazel E. Warburton, et al. (2005) p53 regulation and function in renal cell carcinoma. Cancer Research 65, 6498-6503.
      		•
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision10-September-2008 JSW
      SynonymsAnti-Ubiquitin Protein Ligase, Anti-p53 Binding Protein, Anti-Murine Double Minute Chromosome-2
      ApplicationFrozen Sections (1-5 µg/ml, see application references)
      Immunoblotting (0.5-2 µg/ml, chemiluminescence)
      Immunofluorescence (1-5 µg/ml)
      Immunoprecipitation (1 µg/sample)
      Paraffin Sections (1-5 µg/ml, heat pre-treatment required, see application references)
      DescriptionPurified mouse monoclonal antibody (see application references). Recognizes the ~90 kDa (apparent MW) MDM2 protein. Also recognizes isoforms at ~57 and ~74/76 kDa.
      BackgroundIncreased expression of proto-oncogenes due to gene amplification can lead to cellular transformation in the absence of other mutagenic events. Recently, a novel gene termed MDM2, first identified in mouse as a small acentromeric extrachromosomal element, was shown to become oncogenic upon amplification and tumorigenic when overexpressed in NIH3T3 and Rat2 cells. The human homolog of MDM2 gene has been isolated and mapped to chromosome 12q13-q14, a region that is found to be amplified in human sarcomas. Sequence analysis of the murine, rat, and human MDM2 genes suggests that MDM2 may be involved in transcriptional regulation. MDM2 contains two putative metal-binding motifs, one of which shares similarity to known zinc finger transcriptional activators. MDM2 also contains a putative nuclear localization signal and an acidic domain of the type found in transcriptional activators. A functional role for MDM2 has recently been identified on the basis of experiments which demonstrate that MDM2 forms a stable complex with p53 in vivo. Furthermore, over-expression of MDM2 inhibits the ability of wild type p53 to stimulate expression of target genes, and this inhibition appears to result from MDM2 binding to the acidic activation domain of p53, thereby preventing p53 from directly contacting the transcriptional machinery. Interestingly, wild type p53 appears to positively regulate expression of the MDM2 gene. MDM2 amplification has been observed in sarcomas, and direct analysis of the MDM2 and p53 genes in sarcomas indicates that one or the other but not both of these genes is mutated in 70% of the tumors. Thus, it appears that genetic alterations in either p53 or MDM2 represent alternative mechanisms for inactivating the same growth suppressive pathway. Regulation of MDM2 expression by p53 also represents a potential feed back control of p53 function.
      HostMouse
      Immunogen speciesHuman
      Immunogenhuman MDM2
      Epitopewithin amino acids 26-169 of human MDM2
      CloneIF2
      IsotypeIgG2b
      Specieshuman, not mouse
      Positive controlOSA-CL cells
      FormLiquid
      FormulationIn 50 mM sodium phosphate buffer, 0.2% gelatin.
      Concentration Label Please refer to vial label for lot-specific concentration
      Preservative≤0.1% sodium azide (100 μg only)
      CommentsAlthough the amino acid sequence of MDM2 predicts a protein with a molecular mass of approximately 54 kDa, MDM2 protein migrates on SDS/PAGE with an apparent mobility of 90 kDa.

      Immunoblotting Protocol
      MDM2 (Ab-1) can be used to detect MDM2 by Western blot of proteins previously separated by SDS/PAGE and electrophoretically transferred onto nitrocellulose membranes. The proteins are reacted with the monoclonal antibody and visualized using an HRP conjugated goat anti-mouse antibody with chemiluminescent detection.

      Materials
      Equipment:
      • Electrophoresis apparatus
      • Electroblotting apparatus
      • Rocker platform

      Solutions and Reagents
      • Anti-MDM2 (Ab-1) Mouse mAb (IF2) Cat. No. OP46 or OP46T
      • HRP conjugated goat anti-mouse IgG heavy and light chains (e.g. Cat. No. 401215)
      • Chemiluminescence detection system
      • ELB Buffer (include a cocktail of proetease inhibitors, such as 0.5 µg/ml leupeptin, 1 µg/ml pepstatin, 1 mM EDTA and 0.2 mM PMSF): 50 mM Hepes pH 7.0, 250 mM NaCl, 0.5 mM EDTA, 0.1% Nonidet P-40 Alternative
      • SDS-PAGE (7% acrylamide)
      • Phosphate buffered saline (PBS) pH 7.4; 1 Liter: 0.2 g KCl, 0.2 g KH2PO4, 8 g NaCl, 1.15 g Na2HPO4
      • PBS/0.1% Tween®-20 detergent (PBST)
      • 3% Non-fat Dry Milk in PBST

      Procedure
      1. Lyse cells in ELB Buffer. (Alternatively, cells can be lysed in RIPA Buffer or directly into 1x Laemmli Sample Buffer).
      2. Electrophorese 50-100 µg lysate using a 7% acrylamide gel.
      3. Transfer the protein samples from the polyacrylamide gel onto a nitrocellulose membrane using an electroblotting apparatus.
      4. Block the membrane for 1 h in PBST containing 3% non-fat dry milk at room temperature with rocking. Use about 1 ml per cm2 of membrane.
      5. Incubate the membrane with 1 µg/ml Anti-MDM2 (Ab-1) Mouse mAb (IF2) in 3% non-fat dry milk/ PBST for 1 h at room temperature with rocking.
      6. Wash the membrane 3 times, 15 min each, in PBST at room temperature with rocking.
      7. Incubate the membrane with HRP conjugated goat anti-mouse IgG heavy and light chain antibody, diluted according to the supplier’s instructions, in 3% non-fat dry milk/ PBST at room temperature for 1 h.
      8. Wash the membrane 4 times, 15 min each, in PBST at room temperature with rocking.
      9. Develop the membrane using chemiluminescent detection reagents according to manufacturer instructions.
      10. Expose the membrane to film for ten minutes. Adjust subsequent exposure times as needed.
      Storage +2°C to +8°C
      Do Not Freeze Yes
      Toxicity Standard Handling
      ReferencesGorgoulis, V.G., et al. 1996. J. Pathol. 180, 129.
      Marchetti, A., et al. 1995. J. Pathol. 175, 31.
      Barak, Y., et al. 1993. EMBO J. 12, 461.
      Ladanyi, M., et al. 1993. Cancer Res. 53, 16.
      Leach, F.S., et al. 1993. Cancer Res. 53, 2231.
      Oliner, J.D., et al. 1993. Nature 362, 857.
      Momand, J., et al. 1992. Cell 69, 1237.
      Oliner, J.D., et al. 1992. Nature 358, 80.
      Fakharzadeh, S.S., et al. 1991. EMBO J. 10, 1565.
      Citation
    • Hazel E. Warburton, et al. (2005) p53 regulation and function in renal cell carcinoma. Cancer Research 65, 6498-6503.
      		•
      Application referencesOriginal Clone, Frozen Sections Leach, F. S., et al. 1993. Cancer Res. 53, 2231. Paraffin Sections Marchetti, A., et al. 1995. J. Pathol. 175, 31.